nomlabofusp
nomlabofusp: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Larimar Therapeutics, Inc. (LRMR) | Phase 2 |
Clinical Trials (1)
A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Nomlabofusp in Adolescents and Children With Friedreich's Ataxia
Frequently asked questions
Who is developing nomlabofusp?
nomlabofusp is being developed by Larimar Therapeutics, Inc..
How many clinical trials involve nomlabofusp?
BioSniper tracks 1 clinical trial involving nomlabofusp.
Get deeper analysis on nomlabofusp
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis